Kestra Medical Technologies vs Xtant Medical Holdings
Xtant Medical Holdings is the larger business, with $134m of revenue in fiscal 2025 against $95.1m for Kestra Medical Technologies (1.4 times as much). Kestra Medical Technologies grew faster (59.0% against 14.2%). Xtant Medical Holdings kept more of each dollar of sales as profit: a net margin of 3.7% against -138.4%. Kestra Medical Technologies carries less debt relative to equity (16.4% against 55.7%).
| Latest fiscal year | Kestra Medical TechnologiesKMTS, 2026 | Xtant Medical HoldingsXTNT, 2025 |
|---|---|---|
| Revenue | $95.1m | $134m |
| Revenue growth | 59.0% | 14.2% |
| Net income | −$132m | $5.0m |
| Operating margin | -141.6% | 5.4% |
| Net margin | -138.4% | 3.7% |
| Return on equity | -56.6% | 10.6% |
| Free cash flow | −$117m | $10.2m |
| Cash | $99.7m | $17.1m |
| Total debt | $42.6m | $28.4m |
| Debt to equity | 16.4% | 55.7% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 443 | 151 |
| Market value | $1.74bn | $40.6m |
| Price vs our value range | — | — |
| Moat score | — | 38 (Weak) |
| Insider trades, 12 months | 1 buys, 49 sales | 0 buys, 0 sales |